Author

D. C. Thompson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:metabolomics· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

D. J. Orlicky· 2 shared G. Charkoftaki· 2 shared V. Vasiliou· 2 shared Y. Chen· 2 shared Y. Wang· 2 shared A. Santos-Neto· 1 shared B. Thompson· 1 shared C. H. Johnson· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

D. J. Orlicky

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Endocrine pancreas-specific Gclc gene deletion causes a severe diabetes phenotype

E. A. Davidson, Y. Chen, S. Singh, D. J. Orlicky, B. Thompson, Y. Wang, G. Charkoftaki, T. Furnary, R. L. Cardone, R. G. Kibbey, C. T. Shearn, D. W. Nebert, D. C. Thompson, V. Vasiliou

This study shows that deleting the Gclc gene in the endocrine pancreas of mice leads to severe diabetes due to oxidative stress and islet dysfunction.

bioRxiv · Jun 13, 2023 · PreprintPhysiology

Novel insights into the mode of action of 1,4-dioxane using a systems screening approach

V. Vasiliou, G. Charkoftaki, J. P. Golla, A. Santos-Neto, D. J. Orlicky, R. Garcia-Milian, Y. Chen, N. J. W. Rattray, Y. Cai, Y. Wang, C. T. Shern, V. Mironova, Y. Wang, C. H. Johnson, D. C. Thompson

This study investigates the toxic effects of 1,4-dioxane in mice using histopathology and multi-omics approaches, finding DNA damage counterbalanced by repair mechanisms with no systemic metabolic impact.

bioRxiv · Dec 27, 2020 · PreprintPharmacology & Toxicology